kazuhiro tsuchiya, m.d., masamichi imai, m.d

21
Consecutive Acquisition of Time- resolved Contrast-enhanced MRA and Perfusion MR Imaging of Brain Tumors with a Contrast Dose of 16 mL Kazuhiro Tsuchiya, M.D., Masamichi Imai, M.D. Maiko Yoshida, M.D., Hidekatsu Tateishi, M.D., Toshiaki Nitatori, M.D. Department of Radiology, Kyorin University Faculty of Medicine Mitaka, Tokyo, Japan

Upload: leda

Post on 21-Mar-2016

66 views

Category:

Documents


2 download

DESCRIPTION

Consecutive Acquisition of Time-resolved Contrast-enhanced MRA and Perfusion MR Imaging of Brain Tumors with a Contrast Dose of 16 mL. Kazuhiro Tsuchiya, M.D., Masamichi Imai, M.D. Maiko Yoshida, M.D., Hidekatsu Tateishi, M.D., Toshiaki Nitatori, M.D. - PowerPoint PPT Presentation

TRANSCRIPT

Page 1: Kazuhiro Tsuchiya, M.D., Masamichi Imai, M.D

Consecutive Acquisition of Time-resolved Contrast-enhanced MRA and Perfusion MR Imaging of Brain Tumors

with a Contrast Dose of 16 mL

Kazuhiro Tsuchiya, M.D., Masamichi Imai, M.D.Maiko Yoshida, M.D., Hidekatsu Tateishi, M.D., Toshiaki Nitatori, M.D.

Department of Radiology, Kyorin University Faculty of MedicineMitaka, Tokyo, Japan

Page 2: Kazuhiro Tsuchiya, M.D., Masamichi Imai, M.D

Background

In the diagnosis of brain tumors, perfusion MR imaging (PWI) can show tumor hemodynamics closely related to vascularity and tumor gradeAronen HJ, Radiology 1994; Sugahara T, AJR 1994; Knoop EA, Radiology 1999

Time-resolved contrast-enhanced MRA (TCMRA) is another technique that can demonstrate tumor hemodynamics similarly to conventional angiography

Yoshikawa T, Eur Radiol 2000; Zou Z, J Magn Reson Imaging 2008

Because of NSF, it is recommended to use a required minimum dose of Gd-based contrast media when its use is indicated

Page 3: Kazuhiro Tsuchiya, M.D., Masamichi Imai, M.D

To assess the feasibility and value of consecutive acquisition of PWI and TCMRA in patients with brain tumor in one session using a 16-mL total dose of Gd-based contrast material

This dose was chosen as a 17-mL package of a kind of Gd-based contrast agent (ProHance, Bracco, Milan, Italy) is available in our country as well as in many other countries

Purpose

Page 4: Kazuhiro Tsuchiya, M.D., Masamichi Imai, M.D

28 consecutive patients with brain tumor

- high-grade glioma, 8 pts; low-grade glioma, 1 pt; metastasis, 5 pts; meningioma, 5 pts; lymphoma, 2 pts; others, 2 pts (esthesioneuroblastoma and cavernous hemangioma) - unproven, 5 pts

body weight range, 45-82 kg (average, 58.9 kg)

14 males and 14 femalesage range, 28-82 years (average, 61.3 years)

Subjects

Page 5: Kazuhiro Tsuchiya, M.D., Masamichi Imai, M.D

MR imager: 1.5-T system (EXCELART Vantage, Toshiba Medical Systems, Tochigi, Japan)

Imaging protocol: 1) Conventional precontrast sequences

T1WI, T2WI, FLAIR, and DWI

2) TCMRA (3D fast gradient-echo sequence with parallel

imaging and an efficient k-space filling method)

3) PWI (gradient-echo echo-planar sequence)

4) Postcontrast T1WI

Methods-1 (Imaging Technique)

Page 6: Kazuhiro Tsuchiya, M.D., Masamichi Imai, M.D

Methods-2 (Imaging Technique)

Table 1: Scanning parameters

  TCMRA PWISequence 3D fast field-echo gradient-echo EPI

TR (ms)/TE (ms)/flip angle 3.1/0.9/20 1500/60/90

Section/slab thickness (mm) 75 5

FOV (mm) 260 x 280 260 x 280

Imaging matrix 128 x 256 128 x 128

Imaging plane Sagittal, coronal, or axial Axial

Scanning time (sec) 60 60

Postprocessing <10 min <1 min

Others 7.5 mm x 10 partitions 10 sections

Page 7: Kazuhiro Tsuchiya, M.D., Masamichi Imai, M.D

Contrast injection: 8 mL of Gd-based contrast material and 22 mL of flush saline at a rate of 3 mL/sec from an antecubital vein using a power injector for both TCMRA and PWI

Image reconstruction: 1) TCMRA: WS and/or MR imager console

2) PWI: WS (AZE Virtual Place)

Methods-3 (Imaging Technique)

Page 8: Kazuhiro Tsuchiya, M.D., Masamichi Imai, M.D

(1) Visual assessment of TCMRA and perfusion maps (rCBF, rCBV, and MTT)

- Grade 1 (poor): tumor was not delineated/contrast with the normal brain was absent (TCMRA/PWI)

- Grade 2 (fair): tumor was delineated but vascularity and adjacent vessels were incompletely visualized/ tumor was delineated but contrast with the normal brain was poor (TCMRA/PWI)

- Grade 3 (good): tumor vascularity and adjacent vessels were clearly depicted/ tumor was depicted with good contrast with the normal brain (TCMRA/PWI)

Determined by consensus of two experienced neuroradiologists

Methods-4 (Image Assessment)

Page 9: Kazuhiro Tsuchiya, M.D., Masamichi Imai, M.D

(2) Information additionally obtained by the two techniques was assessed comparing with the final pathological diagnosis

Methods-5 (Image Assessment)

Page 10: Kazuhiro Tsuchiya, M.D., Masamichi Imai, M.D

Results-1

(1) Visual assessment of TCMRA and perfusion maps (rCBF, rCBV, and MTT)

Table 2: Scores of image assessment

In all patients, we obtained TCMRA images and three kinds of perfusion maps that allowed assessment of tumor hemodynamics

Page 11: Kazuhiro Tsuchiya, M.D., Masamichi Imai, M.D

Results-2

(2) Information additionally obtained by the two techniques

Table 3: Comparison between the preoperative Dx and the histological Dx in 23 pts

Note,-GBM indicates glioblastoma; AOA, anaplastic oligoastrocytoma

Page 12: Kazuhiro Tsuchiya, M.D., Masamichi Imai, M.D

Case 1: A 68-year-old man with glioblastoma

rCBV (mL/100g)

A B C

T2-weighted (A) and postcontrast T1-weighted (B) images suggest glioblastoma. rCBV map (C) shows elevated CBV compatible with glioblastoma. TCMRA (D) also shows irregular stain and early venous drainage suggestive of glioblastoma. In this patient, a correct preoperative diagnosis was made without TCMRA or PWI.

Page 13: Kazuhiro Tsuchiya, M.D., Masamichi Imai, M.D

Case 1: A 68-year-old man with glioblastoma

TCMRA

A B D

T2-weighted (A) and postcontrast T1-weighted (B) images suggest glioblastoma. rCBV map (C) shows elevated CBV compatible with glioblastoma. TCMRA (D) also shows irregular stain and early venous drainage suggestive of glioblastoma. In this patient, a correct preoperative diagnosis was made without TCMRA or PWI.

Page 14: Kazuhiro Tsuchiya, M.D., Masamichi Imai, M.D

Case 2: A 40-year-old woman with metastasis from breast cancer

A B CrCBV (mL/100g)

T2-weighted (A) and postcontrast T1-weighted (B) images show a mass in the left parietal lobe that can be metastasis or high-grade glioma. rCBV map (C) shows elevated CBV at margins of the mass and TCMRA (D) also shows a faint stain. Although the preoperative diagnosis was high-grade glioma, the final diagnosis after surgery was metastasis from breast cancer. In retrospect, findings of TCMRA and PWI may have been suggestive of metastasis.

Page 15: Kazuhiro Tsuchiya, M.D., Masamichi Imai, M.D

Case 2: A 40-year-old woman with metastasis from breast cancer

A B DTCMRA

T2-weighted (A) and postcontrast T1-weighted (B) images show a mass in the left parietal lobe that can be metastasis or high-grade glioma. rCBV map (C) shows elevated CBV at margins of the mass and TCMRA (D) also shows a faint stain. Although the preoperative diagnosis was high-grade glioma, the final diagnosis after surgery was metastasis from breast cancer. In retrospect, findings of TCMRA and PWI may have been suggestive of metastasis.

Page 16: Kazuhiro Tsuchiya, M.D., Masamichi Imai, M.D

Case 3: An 80-year-old man with metastasis from rectal cancer

A CB rCBV (mL/100g)

T2-weighted (A) and postcontrast T1-weighted (B) images show ring-like mass in the cerebellar vermis that can be metastasis or high-grade glioma. rCBV map (C) shows slightly elevated CBV at margins and TCMRA (D) also shows a very faint stain. These findings are suggestive of metastasis. The final diagnosis after surgery was metastasis from rectal cancer. In this patient, a correct diagnosis of metastasis was made with findings of TCMRA and PWI

Page 17: Kazuhiro Tsuchiya, M.D., Masamichi Imai, M.D

Case 3: An 80-year-old man with metastasis from rectal cancer

A B D

T2-weighted (A) and postcontrast T1-weighted (B) images show ring-like mass in the cerebellar vermis that can be metastasis or high-grade glioma. rCBV map (C) shows slightly elevated CBV at margins and TCMRA (D) also shows a very faint stain. These findings are suggestive of metastasis. The final diagnosis after surgery was metastasis from rectal cancer. In this patient, a correct diagnosis of metastasis was made with findings of TCMRA and PWI

Page 18: Kazuhiro Tsuchiya, M.D., Masamichi Imai, M.D

Discussion-1

Our basic idea was that, if the same amount of contrast material was employed, it was preferable to use it in a manner that could provide more diagnostic information in establishing the diagnosis. In this regard, we confirmed that, by using 8 mL each, consecutive acquisition of TCMRA and PWI could yield images of sufficient diagnostic value

As for PWI, it has been reported that, as extravasation of contrast agent due to disruption of the blood-brain barrier occurs in some tumors, the administration of a predose of Gd-based contrast material is effective to prevent artificial lowered estimation of rCBV (Boxermann JL, AJNR 2006). Although there is a study that reported that no significant difference between PWIs with and without a predose (Spampinato MV, Neuroradiology 2006), our study order (TCMRA followed by PWI) may have worked well in this regard

Page 19: Kazuhiro Tsuchiya, M.D., Masamichi Imai, M.D

Discussion-2

In six of the 23 patients with histological diagnosis (26.1%), TCMRA and/or PWI contributed to the glioma grading or making the differential diagnosis. In 13 patients (56.5%), however, conventional MR findings were sufficient to make the correct diagnosis and no additional information was obtained by TCMRA and/or PWI. Therefore, although in a limited part of the patient group, the two techniques provided valuable additional information in the differential diagnosis without additional contrast administration

Page 20: Kazuhiro Tsuchiya, M.D., Masamichi Imai, M.D

It is possible to consecutively perform TCMRA and PWI in this order using 8 mL each of Gd-based contrast material. The two techniques can provide images that facilitate the preoperative differential diagnosis of brain tumors

Conclusion

Page 21: Kazuhiro Tsuchiya, M.D., Masamichi Imai, M.D